Understanding Feline Leukemia Virus in Cats

Feline leukemia virus (FeLV) represents one of the most significant infectious diseases affecting domestic cats worldwide. This retroviral infection has been recognized as a major health concern since its discovery in the 1960s, and it continues to impact cat populations across the globe. Understanding the nature of this disease, how it spreads, and the available diagnostic and preventive options is essential for cat owners and veterinary professionals seeking to protect feline health.

What Is Feline Leukemia Virus?

Feline leukemia virus is a gammaretrovirus that exclusively affects domestic cats and certain wild feline species. Unlike some viruses that remain relatively stable, FeLV has the capacity to undergo significant genetic changes through mutation and recombination. This characteristic contributes to the emergence of viral variants that can behave differently in infected cats, potentially affecting disease severity and progression patterns.

The virus operates as a retrovirus, meaning it uses reverse transcriptase to convert its RNA genome into DNA that integrates into the host cell’s genetic material. This integration process is fundamental to understanding how FeLV establishes persistent infections and why some infected cats maintain the virus for life.

Transmission Routes and Risk Factors

FeLV spreads primarily through direct contact between infected and uninfected cats, particularly via saliva. The virus can be transmitted through multiple pathways, each representing a distinct exposure scenario:

• Saliva contact through grooming, shared food bowls, and litter boxes
• Bite wounds sustained during fights between cats
• Respiratory secretions through close proximity and inhalation
• Maternal transmission from infected mothers to kittens during pregnancy, birth, or through nursing
• Blood transfusions if donors have not been properly screened for FeLV

Certain cats face elevated risk of FeLV exposure based on their lifestyle and environment. Non-pedigree cats, intact males, outdoor cats, and animals in multi-cat households containing five or more individuals experience disproportionately higher exposure rates. Additionally, unvaccinated cats and those residing in geographic areas with high FeLV prevalence face substantially increased susceptibility.

The Infection Process and Immune Response

Once a cat encounters the FeLV virus, the initial infection occurs in the mucous membranes of the oropharynx. From this entry point, the virus replicates in nearby lymphatic tissues, including the tonsils and regional lymph nodes. Through the activity of infected lymphocytes and monocytes, FeLV spreads throughout the bloodstream in what is termed primary viraemia.

As the infection advances, the virus reaches bone marrow, where it infects rapidly dividing precursor cells. This progression triggers secondary viraemia, establishing infection throughout multiple tissue systems including the salivary glands, gastrointestinal epithelium, and respiratory tract.

The outcome of FeLV infection depends critically on the cat’s immune response during the initial infection period, typically within the first twelve weeks following exposure. A robust immune response may control or eliminate the virus, while a weak immune response allows progressive infection to develop.

Classification of FeLV Infection Outcomes

Veterinary researchers have identified four distinct classifications describing how FeLV infection progresses in individual cats:

Abortive Infection: The cat’s immune system successfully prevents the virus from integrating into cellular DNA and establishing viraemia. These cats mount an effective immune response that eliminates the virus before persistent infection develops. They remain virus-free and do not shed FeLV.

Regressive Infection: The cat’s immune system partially controls the virus, preventing active viral replication and shedding. However, FeLV provirus integrates into bone marrow cells, where it remains latent. These cats may experience transient periods of viraemia, particularly during stress or immunosuppression. While clinically healthier than progressively infected cats, they carry the virus indefinitely and require lifelong monitoring.

Progressive Infection: The cat’s immune system fails to control FeLV, resulting in persistent viraemia and continuous viral shedding. These cats demonstrate high viral loads, actively infect other cats, and develop FeLV-associated diseases. Progressive infection typically leads to serious clinical complications and eventual disease progression.

Focal Infection: In rare cases, FeLV becomes sequestered to specific tissues rather than establishing systemic infection. Also termed atypical infection, this classification occurs infrequently and involves localized viral persistence without widespread dissemination.

FeLV Subgroups and Viral Variants

Research has identified multiple FeLV subgroups that differ in their genetic composition and pathogenic properties. Understanding these variants provides insight into the variable disease presentation observed among infected cats:

Diagnostic Approaches for FeLV Detection

Accurate diagnosis of FeLV status is fundamental to clinical management and disease prevention. Multiple diagnostic methods exist, each detecting different aspects of viral infection and offering specific advantages depending on the clinical situation.

Antigen Detection (ELISA and Point-of-Care Tests): These methods identify the FeLV p27 capsid antigen in blood, representing the most commonly used screening approach in clinical practice. These tests can detect viraemia relatively quickly but require interpretation based on the cat’s infection timeline. Following recent exposure, antigen may not be detectable for 3 to 6 weeks, necessitating repeat testing if FeLV exposure cannot be excluded.

Provirus Detection (DNA PCR): Real-time polymerase chain reaction targeting FeLV proviral DNA offers high sensitivity and specificity for identifying cats carrying integrated viral DNA. This method detects all provirus carriers, including both progressively and regressively infected animals. DNA PCR from whole blood proves more sensitive than antigen detection alone for establishing definitive FeLV infection status.

Viral RNA Detection (RT-PCR): Reverse transcriptase PCR can identify viral RNA in plasma, serum, or saliva samples. This method appears positive early in infection and correlates well with antigenaemia when detected in saliva.

Antibody Testing: Detection of neutralising antibodies to FeLV indicates that a cat has mounted an immune response to the virus. Neutralising antibodies typically develop at least 3 weeks after exposure and suggest regressive infection, as progressively infected cats rarely develop protective antibodies.

Interpreting Test Results and Follow-Up Protocols

FeLV diagnosis requires careful interpretation considering the testing timeline relative to exposure. A single negative test does not exclude recent infection if exposure occurred within the previous 6 weeks. In such cases, repeat testing approximately 6 weeks after initial exposure provides definitive clarification of infection status. During this quarantine period, potentially exposed cats should be separated from other animals to prevent transmission.

The presence of provirus in progressively infected cats typically corresponds with high viral loads detected through antigen or RNA testing. In contrast, regressively infected cats test positive for provirus but negative or transiently positive for circulating antigen, reflecting the absence of active viral replication despite latent infection.

Prevention Through Vaccination

Vaccination remains the cornerstone of FeLV prevention for at-risk cats. All cats with potential FeLV exposure should receive protective immunisation following established protocols. The vaccination series typically begins at 8 to 9 weeks of age, with a second dose administered at 12 weeks.

Pre-vaccination screening represents a critical component of vaccination protocols. Cats should be tested for FeLV antigenaemia—and ideally for provirus as well—prior to vaccination. This screening prevents vaccinating already-infected cats, in whom the vaccine provides no clinical benefit and resources are better directed toward managing existing infection.

Blood donors used for transfusions must undergo FeLV testing before donation, with antigen testing supplemented by provirus detection to ensure comprehensive screening and prevent transmission through transfusion.

Clinical Management and Prognosis Considerations

Knowledge of a cat’s FeLV status fundamentally influences clinical management and prognosis assessment. Determining FeLV status in every sick cat allows veterinarians to account for this variable when evaluating disease progression and planning treatment. FeLV-infected cats frequently develop secondary infections and complications that would not occur in FeLV-negative animals, directly affecting treatment selection and expected outcomes.

Cats with progressive FeLV infection commonly develop fatal disease-associated complications. Understanding the specific infection course—whether abortive, regressive, progressive, or focal—enables more accurate prognostic counseling and helps guide decisions regarding treatment intensity and quality-of-life considerations.

Epidemiological Importance and Transmission Prevention

From a population health perspective, identifying FeLV-infected cats serves essential epidemiological functions. In multi-cat households, shelters, and colonies, FeLV-positive cats require segregation from susceptible animals to interrupt transmission chains. Cats with progressive infection shed virus continuously through saliva and other secretions, making isolation particularly important for these animals.

Understanding transmission routes enables targeted prevention strategies. In shelters and rescue facilities, appropriate housing with separate feeding and litter facilities reduces transmission risk. Outdoor cats should be kept indoors to reduce exposure, while intact males engaged in territorial fighting face particularly high risk and benefit from confinement or neutering.

Frequently Asked Questions About FeLV

Can indoor cats get feline leukemia?

Indoor cats face significantly lower risk but remain susceptible if exposed to infected cats or contaminated materials. Strict indoor housing provides excellent protection when maintained consistently.

Is feline leukemia curable?

Currently, no treatment eliminates FeLV from infected cats. Management focuses on supporting immune function and treating secondary infections. Some cats with regressive infection may achieve disease-free status through immune control.

How long do cats live with feline leukemia?

Lifespan varies widely depending on infection type. Regressively infected cats may live years or decades with proper care. Progressively infected cats typically develop serious complications within months to a few years.

Can vaccinated cats get feline leukemia?

Vaccination substantially reduces FeLV risk but provides incomplete protection in some cases. Pre-vaccination screening and booster protocols optimise vaccine effectiveness.